复杂性不明原因黄疸1例报告

高禄化; 聂青和; 赵西太

doi:10.3969/j.issn.1001-5256.2019.04.029

复杂性不明原因黄疸1例报告

DOI: 10.3969/j.issn.1001-5256.2019.04.029

空军军医大学唐都医院传染病科全军感染病诊疗中心

详细信息

中图分类号: R575
计量
- 文章访问数: 1046
- HTML全文浏览量: 15
- PDF下载量: 292
- 被引次数: 0
出版历程
- 出版日期: 2019-04-20

A case of jaundice of unknown origin

Department of Infectious Diseases & The Center of Diagnosis and Treatment for Infectious Diseases of PLA, Tangdu Hospital, Air Force Military Medical University

摘要

摘要:
<正>正常情况下,TBil由来自循环中衰老的红细胞经单核-吞噬细胞系统的破坏、分解后生成。TBil由DBil和IBil组成,前者占80%～85%,后者占15%～20%[1]。当TBil代谢途径出现异常时,可导致TBil水平紊乱,由于某种原因,引起红细胞大量破坏,生成大量的胆红素,超过肝脏的处理和排泄功能;或由于肝细胞广泛受损,致使肝细胞对TBil的摄取、运输、结合、排
- 黄疸 /
- 胆红素 /
- 病例报告
- jaundice /
- bilirubin /
- case reports

HTML全文

参考文献(13)

[1]YANG M, LU MQ. Diagnosis and treatment of hepatocellular jaundice[J]. J Prac Hepatol, 2018, 21 (2) :160-162. (in Chinese) 杨敏, 卢明芹.肝细胞性黄疸的诊断与治疗[J].实用肝脏病杂志, 2018, 21 (2) :160-162.

[2]ARNDTZ K, HIRSCHFIELD GM. The pathogenesis of autoimmune liver disease[J]. Dig Dis, 2016, 34 (4) :327-333.

[3]LI C, LIU HL, ZHU B, et al. Study on the etiology and clinical characteristics of patients with jaundice[J]. China J Modern Med, 2014, 24 (21) :64-69. (in Chinese) 李晨, 刘鸿凌, 朱冰, 等.黄疸待查患者病因及临床特点的研究[J].中国现代医学杂志, 2014, 24 (21) :64-69.

[4]LIU WL, LI F, HE ZX, et al. Analysis of bilirubin UDP-glucuronosyltransferase gene mutations in an unusual Crigler-Najjar syndrome patient[J]. Mol Med Rep, 2012, 6 (3) :667-669.

[5]MA JZ, JI HY, WU HM, et al. A case report of Crigler-Najjar syndrome with Gilbert syndrome and literature review[J]. Chin J Integr Trad West Med Dig, 2017, 25 (4) :317-319. (in Chinese) 马继征, 姬航宇, 吴红梅, 等. Crigler-Najjar综合征合并Gilbert综合征1例报道并文献复习[J].中国中西医结合消化杂志, 2017, 25 (4) :317-319.

[6]MUCHOVL, KRSLOVI, LENCEK M, et al. Gilbert's syndrome—myths and reality[J]. Cas Lek Cesk, 2004, 143 (6) :375-380.

[7]SULLIVAN JI, ROCKEY DC. Diagnosis and evaluation of hyperbilirubinemia[J]. Curr Opin Gastroenterol, 2017, 33 (3) :164-170.

[8]WANG ZW, WANG Y, WANG BY, et al. Clinical features of autoimmune liver disease[J]. World Chin J Dig, 2011, 19 (15) :1568-1573. (in Chinese) 王振威, 王颖, 王炳元, 等.自身免疫性肝病的临床特点[J].世界华人消化杂志, 2011, 19 (15) :1568-1573.

[9]BOCK KW. Homeostatic control of xeno-and endobiotics in the drug metabolizing enzyme system[J]. Atherosclerosis, 2001, 154 (3) :747-754.

[10]LYU JY, HAN T. Concerned about the hot issues of clinical management of severe liver disease[J]. J Clin Hepatol, 2017, 33 (9) :1617-1620. (in Chinese) 吕佳昱, 韩涛.关注重症肝病临床管理的热点问题[J].临床肝胆病杂志, 2017, 33 (9) :1617-1620.

[11]DUAN ZJ, LI LL, JU J, et al. Treatment of hyperbilirubinemia with blood purification in China[J]. World J Gastroenterol, 2006, 12 (46) :7467-7471.

[12]VIGGIANO D, de PASCALE E, MARINELLI G. A comparison among three different apheretic techniques for treatment of hyperbilirubinemia[J]. J Artif Organs, 2018, 21 (1) :110-116.

[13]NIE QH. Progress in the comprehensive treatment of liver failure[J]. J Prac Hepatol, 2013, 16 (1) :17-19. (in Chinese) 聂青和.肝衰竭综合治疗进展[J].实用肝脏病杂志, 2013, 16 (1) :17-19.

施引文献

资源附件(0)

访问统计